Bank Of New York Mellon Corp Tango Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

  • $538 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.41 - $8.29 $499,056 - $1.21 Million
146,351 New
146,351 $1.06 Million
Q3 2022

Nov 14, 2022
BUY
$3.25 - $5.46 $44,889 - $75,413
13,812 Added 10.28%
148,196 $537,000
Q2 2022

Aug 15, 2022
BUY
$3.86 - $8.01 $421,369 - $874,395
109,163 Added 432.83%
134,384 $608,000
Q3 2021

Nov 12, 2021
BUY
$9.56 - $17.3 $241,112 - $436,323
25,221 New
25,221 $326,000

Others Institutions Holding TNGX

# of Institutions
123
Shares Held
91.7M
Call Options Held
3.1K
Put Options Held
1.5K
View Full List

About Tango Therapeutics, Inc.

TNGX Quotes by TradingView
  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $268M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email